Aptamers as tools for target prioritization and lead identification.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Drug Discovery Today

• Publication date

  2002-12-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1359-6446(02)02522-9PMID 12547005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineered allosteric ribozymes as biosensor components.

  2002cited by this paper
• The Effects of Platelet-Derived Growth Factor Antagonism in Experimental Glomerulonephritis Are Independent of the Transforming Growth Factor–β System

  2002cited by this paper
• GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism.

  2002cited by this paper
• The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.

  2002cited by this paper
• In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class

  2002cited by this paper
• Bringing picomolar protein detection into proximity

  2002cited by this paper
• Controlling small guanine–nucleotide-exchange factor function through cytoplasmic RNA intramers

  2001cited by this paper
• RNA interference--2001.

  2001cited by this paper
• Aptamer beacons for the direct detection of proteins.

  2001cited by this paper
• Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technology

  2001cited by this paper
• RNA interference is mediated by 21- and 22-nucleotide RNAs.

  2001cited by this paper
• Automated selection of anti-protein aptamers.

  2001cited by this paper
• Aptamers as reagents for high-throughput screening.

  2001cited by this paper
• DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.

  2001cited by this paper
• Intramers as promising new tools in functional proteomics.

  2001cited by this paper
• [14] In vitro selection of RNA aptamers

  2000cited by this paper
• Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution.

  2000cited by this paper
• Developing aptamers into therapeutics.

  2000cited by this paper
• Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.

  2000cited by this paper
• Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys

  2000cited by this paper
• In vitro selection of signaling aptamers

  2000cited by this paper
• Nucleic acid aptamers-from selection in vitro to applications in vivo.

  2000cited by this paper
• Aptamers as therapeutic and diagnostic agents.

  2000cited by this paper
• Transgenic gene knock-outs: functional genomics and therapeutic target selection.

  2000cited by this paper
• A novel RNA motif that binds efficiently and specifically to the Tat protein of HIV and inhibits the trans‐activation by Tat of transcription in vitro and in vivo

  2000cited by this paper
• In vitro selection of RNA aptamers.

  2000cited by this paper
• Adaptive recognition by nucleic acid aptamers.

  2000cited by this paper
• HIV-1 Reverse Transcriptase-Pseudoknot RNA Aptamer Interaction Has a Binding Affinity in the Low Picomolar Range Coupled with High Specificity*

  2000cited by this paper
• Anti-idiotype RNAs that mimic the leucine-rich nuclear export signal and specifically bind to CRM1/exportin 1.

  2000cited by this paper
• VEGF(165) mediates glomerular endothelial repair.

  1999cited by this paper
• RNA aptamers as effective protein antagonists in a multicellular organism.

  1999cited by this paper
• Cytoplasmic RNA modulators of an inside-out signal-transduction cascade.

  1999cited by this paper
• A high throughput platform for systematic evolution of ligands by exponential enrichment (SELEX).

  1999cited by this paper
• Aptamers: an emerging class of molecules that rival antibodies in diagnostics.

  1999cited by this paper
• Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.

  1999cited by this paper
• 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165)

  1998cited by this paper
• Renal microvascular assembly and repair: power and promise of molecular definition.

  1998cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.

  1998cited by this paper
• Automated RNA Selection

  1998cited by this paper
• RNA Molecules That Bind to and Inhibit the Active Site of a Tyrosine Phosphatase*

  1998cited by this paper
• Integrins and inside-out signal transduction: converging signals from PKC and PIP3.

  1997cited by this paper
• Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor

  1997cited by this paper
• Rational design of allosteric ribozymes.

  1997cited by this paper
• A specific RNA hairpin loop structure binds the RNA recognition motifs of the Drosophila SR protein B52

  1997cited by this paper
• Expression of small, therapeutic RNAs in human cell nuclei

  1997cited by this paper
• In vitro selection of nucleic acid aptamers that bind proteins.

  1996cited by this paper
• An enzyme-linked oligonucleotide assay

  1996cited by this paper
• Inhibitory DNA ligands to platelet-derived growth factor B-chain.

  1996cited by this paper
• A SELEX primer.

  1996cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• The emerging concept of vascular remodeling.

  1994cited by this paper
• Vascular permeability factor: A unique regulator of blood vessel function

  1991cited by this paper
• HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.

  1991cited by this paper
• In vitro selection of RNA molecules that bind specific ligands

  1990cited by this paper
• Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

  1990cited by this paper

• Progress in biosensing applications of isothermal nucleic acid amplification techniques

  2025cites this paper
• Role of aptamer technology in extracellular vesicle biology and therapeutic applications.

  2024cites this paper
• Biosensors based on functional nucleic acids and isothermal amplification techniques.

  2022cites this paper
• Novel Aptamer-Based Small-Molecule Drug Screening Assay to Identify Potential Sclerostin Inhibitors against Osteoporosis

  2021influential citation
• Challenges of SELEX and Demerits of Aptamer-Based Methods

  2018cites this paper
• Bioinspired Design of Lysolytic Triterpenoid-peptide Conjugates that Kill African Trypanosomes

  2018cites this paper
• Recent Advances in Potential Applications of Biosensors

  2017cites this paper
• A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.

  2016cites this paper
• Using a Sequence of Estrogen Response Elements as a DNA Aptamer for Estrogen Receptors In Vitro

  2015cites this paper
• Recent Developments in Affinity Chromatography by Panagiotis Spyropoulos April , 2014

  2014cites this paper
• Progress in selection and biomedical applications of aptamers.

  2014cites this paper
• Aptamer Biosensor for Antibiotic Residues Detection in Food Analysis

  2013cites this paper
• Parasite-specific aptamers as biosynthetic reagents and potential pharmaceuticals.

  2012cites this paper
• Aptamers in Research and Drug Development

  2012cites this paper
• High performance aptamer affinity chromatography for single-step selective extraction and screening of basic protein lysozyme.

  2012cites this paper
• Label Free Inhibitor Screening of Hepatitis C Virus (HCV) NS5B Viral Protein Using RNA Oligonucleotide

  2011cites this paper
• Microfluidic aptameric affinity sensing of vasopressin for clinical diagnostic and therapeutic applications

  2011cites this paper
• Methods To Identify Aptamers against Cell Surface Biomarkers

  2011cites this paper
• icrofluidic aptameric affinity sensing of vasopressin for clinical diagnostic nd therapeutic applications

  2011cites this paper
• Strategies for the discovery of therapeutic aptamers

  2011cites this paper
• Quantum-dots-based detection of hepatitis C virus (HCV) NS3 using RNA aptamer on chip

  2010cites this paper
• Streptavidin-Coated Magnetic Beads for DNA Strand Separation Implicate a Multitude of Problems During Cell-SELEX

  2009cites this paper
• An Aptameric Microfluidic System for Specific Purification, Enrichment, and Mass Spectrometric Detection of Biomolecules

  2009cites this paper
• A RNA‐Based Approach towards Small‐Molecule Inhibitors

  2009cites this paper
• Function of the anterior gradient protein family in cancer

  2009cites this paper
• An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro.

  2008cites this paper
• Neuropeptide Techniques

  2008influential citation
• CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics

  2008cites this paper
• Proteomics: technologies for protein analysis.

  2008cites this paper
• Integrative Technologies for Neuropeptide Characterization

  2008cites this paper
• Characterisation of aptamers for therapeutic studies

  2007cites this paper
• Functional nucleic acids in high throughput screening and drug discovery.

  2007cites this paper
• Considerations for target validation and industrial approaches.

  2007cites this paper
• SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

  2007cites this paper
• Complex SELEX against target mixture: Stochastic computer model, simulation, and analysis

  2007cites this paper
• Aptamer-based capture molecules as a novel tool to isolate target cells and promote cell adhesion

  2006cites this paper
• DNA and RNA aptamers: from tools for basic research towards therapeutic applications.

  2006cites this paper
• Nucleic acid aptamers as adjuncts to vaccine development.

  2006cites this paper
• Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes.

  2006cites this paper
• RNA aptamers as potential pharmaceuticals against infections with African trypanosomes.

  2006cites this paper
• Co-expression of anti-NFκB RNA aptamers and siRNAs leads to maximal suppression of NFκB activity in mammalian cells

  2006cites this paper
• Potential diagnostic applications of biosensors: current and future directions

  2006cites this paper
• Peptide aptamers as guides for small-molecule drug discovery.

  2006cites this paper
• Aptamers—basic research, drug development, and clinical applications

  2005cites this paper
• Aptamers as tools for target validation.

  2005cites this paper
• Massive Identification of Cancer-Specific Nucleic Acid Ligands

  2005cites this paper
• Aptamers against extracellular targets for in vivo applications.

  2005cites this paper
• Functional informatics: convergence and integration of automation and bioinformatics.

  2004cites this paper
• Proteomic technologies for cancer target validation.

  2004cites this paper
• Targeted drug delivery (Site specific drug delivery)

  2004cites this paper
• Overview of target validation and the impact of oligonucleotides.

  2004cites this paper
• Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

  2004cites this paper
• Orphan GPCR target validation.

  2004cites this paper
• Nucleic Acid Aptamers as Tools and Drugs: Recent Developments

  2003cites this paper
• What constitutes target validation

  2003cites this paper
• Identification and application of functional RNAs

  2003cites this paper
• Target validation using human tissue: from gene expression to function

  2003cites this paper
• Target discovery

  2003cites this paper
• In vitro selection of high-affinity nucleic acid ligands to parasite target molecules.

  2003cites this paper